Hetal Patel

5.5k total citations · 1 hit paper
35 papers, 3.5k citations indexed

About

Hetal Patel is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Hetal Patel has authored 35 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Genetics. Recurrent topics in Hetal Patel's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Hetal Patel is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Advanced Fluorescence Microscopy Techniques (4 papers). Hetal Patel collaborates with scholars based in United Kingdom, United States and Netherlands. Hetal Patel's co-authors include Klaus J. Busam, Toshiro Kageshita, Boris C. Bastian, Jane Fridlyand, Heinz Kutzner, John A. Curtin, Eva‐Bettina Bröcker, Setsuya Aiba, Kwang‐Hyun Cho and Philip E. LeBoit and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Hetal Patel

32 papers receiving 3.4k citations

Hit Papers

Distinct Sets of Genetic Alterations in Melanoma 2005 2026 2012 2019 2005 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hetal Patel United Kingdom 19 2.3k 2.1k 476 469 377 35 3.5k
Kimberly B. Dahlman United States 21 2.3k 1.0× 1.7k 0.8× 451 0.9× 575 1.2× 225 0.6× 38 3.2k
Farbod Darvishian United States 37 2.4k 1.0× 1.9k 0.9× 833 1.8× 1.2k 2.6× 241 0.6× 119 4.3k
Uwe Trefzer Germany 30 2.8k 1.2× 2.7k 1.3× 1.1k 2.3× 341 0.7× 169 0.4× 78 4.5k
Thinle Chodon United States 22 3.3k 1.4× 3.2k 1.5× 1.4k 2.9× 461 1.0× 297 0.8× 33 5.2k
Patricia Brafford United States 18 2.6k 1.1× 1.4k 0.7× 505 1.1× 756 1.6× 561 1.5× 24 3.5k
Oddbjørn Straume Norway 31 2.8k 1.2× 2.4k 1.1× 495 1.0× 1.3k 2.8× 337 0.9× 69 4.6k
Gabriella Liszkay Hungary 22 2.8k 1.2× 2.9k 1.4× 782 1.6× 311 0.7× 132 0.4× 82 4.0k
Peter M. Haverty United States 29 2.4k 1.0× 846 0.4× 298 0.6× 677 1.4× 132 0.4× 38 3.3k
Michael Hölzel Germany 33 2.2k 1.0× 1.7k 0.8× 1.3k 2.8× 588 1.3× 282 0.7× 96 4.3k
Lori S. Friedman United States 42 4.8k 2.1× 2.5k 1.2× 530 1.1× 1.1k 2.3× 455 1.2× 106 7.4k

Countries citing papers authored by Hetal Patel

Since Specialization
Citations

This map shows the geographic impact of Hetal Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hetal Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hetal Patel more than expected).

Fields of papers citing papers by Hetal Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hetal Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hetal Patel. The network helps show where Hetal Patel may publish in the future.

Co-authorship network of co-authors of Hetal Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Hetal Patel. A scholar is included among the top collaborators of Hetal Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hetal Patel. Hetal Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Patel, Hetal, et al.. (2025). SNP Analysis of the SOD1 gene involved in Amyotrophic Lateral Sclerosis (ALS). Journal of Taibah University for Science. 19(1). 1 indexed citations
3.
Tereshchenko, Larisa G., Kazi T. Haq, Stacey J. Howell, et al.. (2024). Electrical Heterogeneity in Hispanic Background Subpopulations. JACC Advances. 3(12). 101225–101225.
4.
5.
Pareek, Sumedha, Riccardo Ballarò, Darlan Conterno Minussi, et al.. (2023). Aerobic Exercise Alters the Melanoma Microenvironment and Modulates ERK5 S496 Phosphorylation. Cancer Immunology Research. 11(9). 1168–1183. 12 indexed citations
6.
Tereshchenko, Larisa G., et al.. (2023). An electrophysiological substrate of COVID-19. Journal of Electrocardiology. 79. 61–65. 1 indexed citations
7.
Gabani, Prashant, Hetal Patel, S Goddu, et al.. (2019). Clinical outcomes and toxicity of proton beam radiation therapy for re-irradiation of locally recurrent breast cancer. Clinical and Translational Radiation Oncology. 19. 116–122. 27 indexed citations
8.
Patel, Hetal, Manikandan Periyasamy, Georgina P. Sava, et al.. (2018). ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment. Molecular Cancer Therapeutics. 17(6). 1156–1166. 111 indexed citations
9.
Periyasamy, Manikandan, Hetal Patel, Chun‐Fui Lai, et al.. (2015). APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer. Cell Reports. 13(1). 108–121. 87 indexed citations
10.
Kaliszczak, Maciej, Hetal Patel, Sebastian H. B. Kroll, et al.. (2013). Development of a cyclin-dependent kinase inhibitor devoid of ABC transporter-dependent drug resistance. British Journal of Cancer. 109(9). 2356–2367. 19 indexed citations
11.
Natarajan, Arun, et al.. (2012). Mass in the Left Atrial Appendage: A Therapeutic Dilemma. Canadian Journal of Cardiology. 29(10). 1329.e13–1329.e15. 2 indexed citations
12.
Tolhurst, Robert S., Ross S. Thomas, Hetal Patel, et al.. (2010). Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth. Breast Cancer Research and Treatment. 128(2). 357–368. 21 indexed citations
13.
Ali, Simak, Dean A. Heathcote, Sebastian H. B. Kroll, et al.. (2009). The Development of a Selective Cyclin-Dependent Kinase Inhibitor That Shows Antitumor Activity. Cancer Research. 69(15). 6208–6215. 129 indexed citations
14.
Patel, Hetal & Myrtle Y. Gordon. (2009). Abnormal centrosome‐centriole cycle in chronic myeloid leukaemia?. British Journal of Haematology. 146(4). 408–417. 23 indexed citations
15.
Patel, Hetal, et al.. (2007). Subcellular distribution of p210BCR-ABL in CML cell lines and primary CD34+ CML cells. Leukemia. 22(3). 559–571. 10 indexed citations
16.
Patel, Hetal, Stephen B. Marley, & Myrtle Y. Gordon. (2006). Detection in primary chronic myeloid leukaemia cells of p210BCR‐ABL1 in complexes with adaptor proteins CBL, CRKL, and GRB2. Genes Chromosomes and Cancer. 45(12). 1121–1129. 16 indexed citations
17.
Wang, Meitian, Hetal Patel, & Rebekka M. Wachter. (2005). X-ray diffraction analysis and molecular-replacement solution of the cyan fluorescent protein dsFP483. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 61(10). 922–924. 2 indexed citations
18.
Curtin, John A., Jane Fridlyand, Toshiro Kageshita, et al.. (2005). Distinct Sets of Genetic Alterations in Melanoma. New England Journal of Medicine. 353(20). 2135–2147. 1937 indexed citations breakdown →
19.
Patel, Hetal, et al.. (2005). Base Catalysis of Chromophore Formation in Arg96 and Glu222 Variants of Green Fluorescent Protein. Journal of Biological Chemistry. 280(28). 26248–26255. 104 indexed citations
20.
Maldonado, Janet L., Jane Fridlyand, Hetal Patel, et al.. (2003). Determinants of BRAF Mutations in Primary Melanomas. JNCI Journal of the National Cancer Institute. 95(24). 1878–1890. 491 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026